Glenmark Pharmaceuticals Ltd has said that the GBR 500 deal signed by the company in May has received the second and final upfront payment of $25 million. With this payment, Glenmark has received the entire upfront payment of $50 million from Sanofi pertaining to the GBR - 500 deal.

comment COMMENT NOW